Analyst Price Targets — HENKY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 8, 2025 9:17 am | Mikheil Omanadze | BNP Paribas | $25.20 | $20.13 | TheFly | Henkel upgraded to Outperform from Neutral at BNP Paribas Exane |
Latest News for HENKY
Henkel AG remains a 'Buy,' trading below intrinsic value despite ongoing fundamental challenges and limited growth visibility. HENKY's recent acquisitions, including Olaplex and Not Your Mother's, add €1.5–1.6 billion in annual sales, expanding its U.S. hair care footprint. Dividend growth has slowed to 1%, but payout remains well-covered; share buybacks and cautious capital allocation continue.
The chemical and consumer-goods company's sales were up 1.7% on an organic basis compared with the same period last year.
Henkel AG and Co. (OTCMKTS:HENKY - Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totaling 58,522 shares, a growth of 90.7% from the March 31st total of 30,694 shares. Based on an average daily volume of 360,337
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for HENKY.
Senate Trading
No Senate trades found for HENKY.
U.S. House Trading
No House trades found for HENKY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.